Immunotherapy, which enhances the immune system's T cell response to eliminate cancer cells, has emerged as a key approach in ...

Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...

A clinical trial at Stanford Medicine has shown that CAR-T cell therapy, a cancer treatment, can effectively treat brain ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

A CAR-T trial is one of several efforts that suggest there’s hope of treating the “worst imaginable childhood brain tumor,” ...

As Sri Lanka's healthcare system struggles to get back on its feet following the election of a new president in September, ...

Japanese scientists conducted a clinical trial using stem cells to treat severe corneal damage. The trial involved four ...

Non-small cell lung cancer (NSCLC) remains a predominant cause of cancer-related mortality worldwide. In recent years, immune checkpoint inhibitors (ICIs) have emerged as a transformative therapeutic ...

Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...

StitchR, a new gene therapy technique, delivers large genes in two parts to treat muscular dystrophies by restoring critical proteins in animal models.

Researchers used base and prime editing to uncover new EGFR gene mutations that affect cancer progression and drug resistance ...

University of Washington-led research, published in 2023, discovered microglia in the brains of people with Alzheimer's ...